Showing results (51-60 of 206) with videos related to
Sort By:
Pageof 21
Substance Abuse Treatment, Prevention, and Policy|June 27, 2026
Staff perceptions of care navigators in medication for opioid use disorder treatment settingsMichael Goetz, Shaquita Andrews-Higgins, Olivia A Davis, et al.Inflammatory Bowel Diseases|April 4, 2017
Predictors of Chronic Opioid Use in Newly Diagnosed Crohn's DiseaseNathan J Pauly, Lamprinos Michailidis, Michael G Kindred, et al.JAMA Network Open|June 25, 2024
Extended-Release Injection vs Sublingual Buprenorphine for Opioid Use Disorder With Fentanyl Use: A Post Hoc Analysis of a Randomized Clinical TrialEdward V Nunes, Sandra D Comer, Michelle R Lofwall, et al.Psychopharmacology|November 10, 2020
Acute administration of oxycodone, alcohol, and their combination on simulated driving-preliminary outcomes in healthy adultsShanna Babalonis, Marion A Coe, Paul A Nuzzo, et al.The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|February 7, 2026
Clinical and demographic characteristics of participants in a hepatitis C treatment trial in rural Kentucky: How policies around treatment access may impact elimination efforts in the United StatesJennifer R Havens, Brittney D Williams, Takako Schaninger, et al.The Journal of Continuing Education in the Health Professions|June 17, 2026
Development and Early Outcomes of Interprofessional Education on Opioid Use Disorder in the Kentucky HEALing Communities StudyChristopher D Cook, Katrina Nickels, John A Lauckner, et al.Preventive Medicine|August 5, 2021
Long-acting buprenorphine injectables: Opportunity to improve opioid use disorder treatment among rural populationsMichelle R Lofwall, Laura C FanucchiDrug and Alcohol Dependence|June 19, 2012
Inability to access buprenorphine treatment as a risk factor for using diverted buprenorphineMichelle R Lofwall, Jennifer R HavensJournal of Psychiatric Practice|March 19, 2015
Challenges of the capacity evaluation for the consultation-liaison psychiatristMegan M White, Michelle R LofwallPsychopharmacology|June 9, 2021
Relative potency of intravenous oxymorphone compared to other µ opioid agonists in humans - pilot study outcomesShanna Babalonis, Sandra D Comer, Jermaine D Jones, et al.Pageof 21